Heron Therapeutics Inc (HRTX)

16.50 +0.06  +0.36% NASDAQ Oct 23, 20:00 USD

Heron Therapeutics Cash from Investing (Quarterly):

32.41M for June 30, 2020
View 4,000+ financial data types
Browse...
View Full Chart

Cash from Investing (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Cash from Investing (Quarterly) Data

View and export this data going back to 1990. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2020 32.41M
March 31, 2020 63.82M
Dec. 31, 2019 -126.36M
Sept. 30, 2019 28.63M
June 30, 2019 41.84M
March 31, 2019 34.11M
Dec. 31, 2018 8.328M
Sept. 30, 2018 -149.26M
June 30, 2018 -97.33M
March 31, 2018 -40.29M
Dec. 31, 2017 -20.36M
Sept. 30, 2017 70.61M
June 30, 2017 2.41M
March 31, 2017 -44.92M
Dec. 31, 2016 4.811M
Sept. 30, 2016 -31.15M
June 30, 2016 18.56M
March 31, 2016 22.66M
Dec. 31, 2015 -56.42M
Sept. 30, 2015 -0.252M
June 30, 2015 0.038M
March 31, 2015 -0.328M
Dec. 31, 2014 -1.021M
Sept. 30, 2014 -0.082M
June 30, 2014 -0.278M
   
March 31, 2014 -0.057M
Dec. 31, 2013 -0.167M
Sept. 30, 2013 -0.977M
June 30, 2013 -0.106M
March 31, 2013 -0.435M
Dec. 31, 2012 -0.426M
Sept. 30, 2012 -0.079M
June 30, 2012 -0.044M
March 31, 2012 -0.423M
Dec. 31, 2011 -0.387M
Sept. 30, 2011 -0.126M
June 30, 2011 0.00
March 31, 2011 0.00
Dec. 31, 2010 -0.003M
Sept. 30, 2010 -0.063M
June 30, 2010 0.00
March 31, 2010 -0.012M
Dec. 31, 2009 0.04M
Sept. 30, 2009 0.16M
June 30, 2009 0.195M
March 31, 2009 0.217M
Dec. 31, 2008 0.301M
Sept. 30, 2008 0.293M
June 30, 2008 0.106M
March 31, 2008 -0.022M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (Quarterly) Benchmarks

Albireo Pharma Inc -0.078M
Gilead Sciences Inc -5.023B
NovaBay Pharmaceuticals Inc 0.00

Cash from Investing (Quarterly) Range, Past 5 Years

Minimum -149.26M Sep 2018
Maximum 70.61M Sep 2017
Average -12.52M
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.